Travere Therapeutics, Inc. (TVTX)
49.92
-0.16
(-0.32%)
USD |
NASDAQ |
Oct 26, 16:00
49.92
0.00 (0.00%)
After-Hours: 17:32
Travere Therapeutics Price : 49.92 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 52.00 | 52.22 | 49.78 | 50.08 | 2.314M |
| Oct 22, 2026 | 52.34 | 53.12 | 51.25 | 52.43 | 1.774M |
| Oct 21, 2026 | 52.88 | 54.83 | 52.50 | 52.58 | 2.164M |
| Oct 20, 2026 | 50.43 | 52.70 | 50.40 | 52.30 | 2.058M |
| Oct 19, 2026 | 50.17 | 51.28 | 49.74 | 50.49 | 1.316M |
| Oct 16, 2026 | 52.56 | 52.56 | 49.46 | 49.60 | 1.828M |
| Oct 15, 2026 | 53.94 | 55.57 | 52.63 | 52.79 | 1.981M |
| Oct 14, 2026 | 51.61 | 53.94 | 51.53 | 53.27 | 2.061M |
| Oct 13, 2026 | 51.57 | 52.81 | 51.38 | 51.80 | 1.669M |
| Oct 12, 2026 | 51.74 | 53.35 | 51.74 | 52.02 | 1.424M |
| Oct 09, 2026 | 52.04 | 52.71 | 51.63 | 52.12 | 1.169M |
| Oct 08, 2026 | 53.44 | 53.44 | 51.45 | 52.04 | 1.647M |
| Oct 07, 2026 | 55.41 | 56.61 | 53.28 | 53.44 | 3.424M |
| Oct 06, 2026 | 57.86 | 58.77 | 55.16 | 55.98 | 3.108M |
| Oct 05, 2026 | 57.31 | 58.60 | 55.86 | 57.67 | 2.644M |
| Oct 02, 2026 | 57.21 | 57.53 | 56.34 | 56.93 | 1.722M |
| Oct 01, 2026 | 58.64 | 59.58 | 56.23 | 56.85 | 2.395M |
| Sep 30, 2026 | 60.35 | 60.47 | 58.83 | 58.88 | 1.561M |
| Sep 29, 2026 | 61.04 | 61.87 | 59.33 | 59.99 | 1.565M |
| Sep 28, 2026 | 59.05 | 61.75 | 58.71 | 61.57 | 1.235M |
| Sep 25, 2026 | 60.89 | 60.89 | 59.05 | 59.44 | 1.206M |
| Sep 24, 2026 | 60.00 | 60.80 | 59.22 | 60.62 | 1.756M |
| Sep 23, 2026 | 60.39 | 60.89 | 58.32 | 59.83 | 1.714M |
| Sep 22, 2026 | 60.37 | 62.45 | 59.30 | 60.28 | 3.120M |
| Sep 21, 2026 | 63.01 | 63.64 | 61.85 | 62.86 | 1.584M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| TG Therapeutics, Inc. | 54.77 |
| BioMarin Pharmaceutical, Inc. | 55.74 |
| Vertex Pharmaceuticals, Inc. | 517.62 |
| Viridian Therapeutics, Inc. | 23.34 |
| Krystal Biotech, Inc. | 314.92 |
Price Related Metrics
| PS Ratio | 7.983 |
| Price to Book Value | 191.71 |
| Price to Free Cash Flow | 306.56 |
| Earnings Yield | -1.53% |
| Market Cap | 4.701B |